{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":26,"next":"https://hottub.news/v1/items?before=1790675657.633624&entity=Q731938","sponsored":0,"items":[{"id":"n_4kn2ov4xwveuy6xk224q","seq":1334098,"kind":"article","title":"Health: AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination","url":"https://www.gdnonline.com/Details/1408377/AstraZeneca,-Daiichi-Sankyo-partner-with-Summit-to-test-cancer-drug-combination","published":"2026-10-02T11:53:15Z","seen":"2026-10-02T11:53:15Z","lang":"en","source":{"id":"gdnonline.com","name":"gdnonline.com","domain":"gdnonline.com"},"via":"gdelt-gkg-english","topics":["health","economy"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q669441","name":"Daiichi Sankyo","type":"org"},{"id":"Q207326","name":"summit","type":"org"}],"story":"st_d37ka6wke3x4h4tdoaka","category":"health","category_p":0.63,"sentiment":"positive","tone":-0.1,"political":0.1},{"id":"n_uqvolwugtjpkbmdyoppa","seq":1311245,"kind":"article","title":"AstraZeneca, Daiichi Sankyo, Summit to Test Drug Combination","url":"https://www.miragenews.com/astrazeneca-daiichi-sankyo-summit-to-test-drug-1754306","published":"2026-10-02T09:38:11Z","seen":"2026-10-02T09:38:11Z","lang":"en","source":{"id":"miragenews.com","name":"miragenews.com","domain":"miragenews.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q669441","name":"Daiichi Sankyo","type":"org"},{"id":"Q207326","name":"summit","type":"org"}],"story":"st_d37ka6wke3x4h4tdoaka","category":"health","category_p":0.33,"sentiment":"neutral","tone":0.15,"political":0.11},{"id":"n_d37ka6wke3x4h4tdoaka","seq":1293969,"kind":"article","title":"AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combo","url":"https://www.sowetan.co.za/news/world/2026-10-02-astrazeneca-daiichi-sankyo-partner-with-summit-to-test-cancer-drug-combo","summary":"AstraZeneca, Daiichi Sankyo, and Summit Therapeutics will jointly test cancer drugs Datroway and ivonescimab in a Phase III trial for triple-negative breast cancer","published":"2026-10-02T07:54:14Z","seen":"2026-10-02T08:16:31Z","lang":"en","country":"ZA","source":{"id":"kite-sowetan-co-za-f35324","name":"sowetan.co.za","domain":"sowetan.co.za"},"via":"kite-sowetan-co-za-f35324","topics":["sci-tech"],"authors":["Reuters Agency"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q669441","name":"Daiichi Sankyo","type":"org"},{"id":"Q207326","name":"summit","type":"org"}],"image":"https://www.sowetan.co.za/resizer/v2/WGEBOEAIFZC5BPAFM7I5LCWTA4.JPG?auth=97408645fec2e2cbc8b39ca8980198215e08218f94b4e505b9ff05631abeb2a8&height=350&smart=true&width=800","story":"st_d37ka6wke3x4h4tdoaka","category":"health","category_p":0.5,"sentiment":"positive","tone":0.3,"political":0.13},{"id":"n_y4wpj6ajcx6d37ugsbca","seq":1290986,"kind":"article","title":"Astra Zeneca i avtal om cancermedicin","title_en":"Astra Zeneca in agreement on cancer medicine","url":"https://www.di.se/live/astra-zeneca-i-avtal-om-cancermedicin","summary":"Läkemedelsbolaget Astra Zeneca har tillsammans med Daiichi Sankyo ingått ett kliniskt samarbete med Summit Therapeutics för utvärdering av läkemedlet Datroway i kombination med läkemedelskandidaten ivonescimab vid behandling av ett flertal cancertyper, inklusive lung- och bröstcancer.","published":"2026-10-02T06:48:59Z","seen":"2026-10-02T07:48:04Z","lang":"sv","country":"SE","source":{"id":"kite-di-se-755352","name":"di.se","domain":"di.se","outlet":{"wikidata":"Q734293","name":"Dagens Industri","type":"newspaper","designations":["newspaper"]}},"via":"kite-di-se-755352","authors":["Nyhetsbyrån Direkt"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"}],"image":"https://static.bonniernews.se/ba/2550f755-9b59-4089-8e12-d9afbc7b86d2.jpeg?width=600","story":"st_y4wpj6ajcx6d37ugsbca","category":"health","category_p":0.56,"category2":"economy-business","sentiment":"neutral","tone":0.17,"political":0.28},{"id":"n_phuyt3cjlmlffh5uvqpq","seq":1281485,"kind":"article","title":"AZ & DS collaboration with Summit for Datroway | Company Announcement","url":"https://www.investegate.co.uk/announcement/rns/astrazeneca--azn/az-ds-collaboration-with-summit-for-datroway/9803807","published":"2026-10-02T06:40:09Z","seen":"2026-10-02T06:40:09Z","lang":"en","country":"GB","source":{"id":"investegate.co.uk","name":"investegate.co.uk","domain":"investegate.co.uk"},"via":"gdelt-gkg-english","topics":["economy","education","health","business"],"authors":["Investegate"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q170323","name":"Nintendo DS","type":"org"},{"id":"Q207326","name":"summit","type":"org"}],"story":"st_phuyt3cjlmlffh5uvqpq","category":"economy-business","category_p":0.71,"sentiment":"positive","tone":0.21,"political":0.03},{"id":"n_6rytd5ihkcpjkwwf37ya","seq":1054028,"kind":"article","title":"AZ verlost Karten für die Infa","title_en":"AZ gives away tickets for the Infa","url":"https://www.waz-online.de/lokales/gifhorn-lk/gifhorn/az-verlost-karten-fuer-die-infa-BKKL5VCOEZAYVEH5DVRIBJA5ZQ.html","summary":"Neun Tage Genuss, Lifestyle und Wohnideen: Mehr als 700 Aussteller zeigen sich vom 10. bis 18. Oktober in sieben Hallen. So können AZ-Leserinnen und -Leser kostenlos dabei sein.","published":"2026-10-01T04:00:02Z","seen":"2026-10-01T04:55:31Z","lang":"de","country":"DE","source":{"id":"kite-wolfsburger-allgemeine-de-85706d","name":"wolfsburger-allgemeine.de","domain":"wolfsburger-allgemeine.de"},"via":"kite-wolfsburger-allgemeine-de-85706d","topics":["lower-saxony"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"}],"image":"https://www.waz-online.de/resizer/v2/5OV43WKCQNGFVF2QCYFIDOJ2NY.jpg?auth=660c4f10a3add919b350156caa11e5fdb85ea0795e3a56b7379186161857bdeb&quality=70&width=596","story":"st_6rytd5ihkcpjkwwf37ya","category":"sport","category_p":0.69,"sentiment":"neutral","tone":0.48,"political":0.05},{"id":"n_ukvyi3fansygt4e5qoma","seq":919812,"kind":"article","title":"Investments & Wealth Institute Announces Keynote Lineup for Experience 2026 in Scottsdale, AZ","url":"http://www.hawaiitelegraph.com/news/279342977/investments-wealth-institute-announces-keynote-lineup-for-experience-2026-in-scottsdale-az","published":"2026-09-30T14:00:00Z","seen":"2026-09-30T14:02:31Z","lang":"en","source":{"id":"hawaiitelegraph.com","name":"hawaiitelegraph.com","domain":"hawaiitelegraph.com"},"via":"gdelt-gkg-english","topics":["business","economy","education","science"],"entities":[{"id":"Q85756737","name":"Investments & Wealth Institute","type":"org"},{"id":"Q49221","name":"Scottsdale","type":"place"},{"id":"Q731938","name":"AstraZeneca","type":"place"}],"story":"st_cboaj7fphqoowapt77qq","category":"economy-business","category_p":0.82,"sentiment":"neutral","tone":0.76,"political":0.02},{"id":"n_f6f6fzvgaqbtqdlnzs5q","seq":892626,"kind":"article","title":"Geen uitsupporters van Israëlische club welkom bij duel van AZ in Europa League","title_en":"No supporters of Israeli club welcome at AZ's Europa League match","url":"https://www.ad.nl/voetbal/geen-uitsupporters-van-israelische-club-welkom-bij-duel-van-az-in-europa-league~a4a69e28","summary":"Het Israëlische Hapoel Beer Sheva mag op 15 oktober geen supporters meenemen naar de Europa League-wedstrijd tegen AZ in Alkmaar. Dat heeft de driehoek (gemeente, politie en Openbaar Ministerie) besloten op basis van openbare veiligheidsafwegingen, meldt AZ op de eigen website.","published":"2026-09-30T08:52:25Z","seen":"2026-09-30T11:43:07Z","lang":"nl","country":"NL","source":{"id":"kite-ad-nl-e37b75","name":"ad.nl","domain":"ad.nl","outlet":{"wikidata":"Q290764","name":"Algemeen Dagblad","type":"newspaper","country":"NL","designations":["daily newspaper"]}},"via":"kite-ad-nl-e37b75","authors":["author"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q18760","name":"UEFA Europa League","type":"event"}],"image":"https://images.ad.nl/MDRlMjgwMGY3MTI5ZjJiMTZkNDEvZGlvLzI3ODM3ODQwMS9maXQtd2lkdGgvNDAw/fans-van-hapoel-zijn-niet-welkom-in-het-afas-stadion-van-az","story":"st_e5ttwo3gyqux6lgsimaa","category":"sport","category_p":0.67,"sentiment":"neutral","tone":-0.19,"political":0.55},{"id":"n_e5ttwo3gyqux6lgsimaa","seq":852187,"kind":"article","title":"Supporters van Israëlische club niet welkom bij duel met AZ","title_en":"Supporters of Israeli club not welcome at match with AZ","url":"https://www.nhnieuws.nl/nieuws/363883/supporters-van-israelische-club-niet-welkom-bij-duel-met-az","summary":"Het Israëlische Hapoel Beer Sheva mag over twee weken geen supporters meenemen naar de Europa League-wedstrijd tegen AZ in Alkmaar. Dat hebben gemeente Alkmaar, de politie en het Openbaar Ministerie besloten op basis van openbare veiligheidsafwegingen, meldt AZ op de eigen website. De club zegt de beslissing te respecteren en zich te richten op 'het veilig en verantwoord organiseren van de wedstrijd'. De veiligheid van supporters, medewerkers, spelers en andere betrokkenen…","published":"2026-09-30T07:53:22Z","seen":"2026-09-30T08:07:30Z","lang":"nl","country":"NL","source":{"id":"kite-nhnieuws-nl-8fcf3b","name":"nhnieuws.nl","domain":"rss.nhnieuws.nl"},"via":"kite-nhnieuws-nl-8fcf3b","entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"}],"image":"https://media.nhnieuws.nl/images/572665.bc322ac.jpg","story":"st_e5ttwo3gyqux6lgsimaa","category":"sport","category_p":0.84,"sentiment":"negative","tone":-0.48,"political":0.35},{"id":"n_s7xuftbrz7mfqusereza","seq":822583,"kind":"article","title":"Contrasting Tarsus Pharmaceuticals (NASDAQ:TARS) & Astrazeneca (NYSE:AZN)","url":"https://www.themarketsdaily.com/2026/09/30/contrasting-tarsus-pharmaceuticals-nasdaqtars-astrazeneca-nyseazn.html","published":"2026-09-30T04:40:20Z","seen":"2026-09-30T04:40:20Z","lang":"en","source":{"id":"themarketsdaily.com","name":"themarketsdaily.com","domain":"themarketsdaily.com"},"via":"gdelt-gkg-english","topics":["economy","business","health"],"authors":["Danessa Lincoln"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"}],"story":"st_s7xuftbrz7mfqusereza","category":"economy-business","category_p":0.34,"category2":"health","sentiment":"neutral","tone":0.13,"political":0.07},{"id":"n_gbl2kwvd2n57nq37uaua","seq":810945,"kind":"article","title":"Access to forest land at border now closed during wall construction in AZ","url":"https://tucson.com/news/local/border/article_bf2bcf78-4e5d-4608-825c-eb295451ef83.html","published":"2026-09-30T00:00:00Z","seen":"2026-09-30T03:21:37Z","lang":"en","source":{"id":"tucson.com","name":"tucson.com","domain":"tucson.com","outlet":{"wikidata":"Q1982939","name":"Arizona Daily Star","type":"newspaper","country":"US","designations":["daily newspaper","newspaper","website"]}},"via":"gdelt-gkg-english","topics":["economy","politics","health","crime"],"authors":["Emily Bregel","Mark Henle","Arizona Republic 2025"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"place"}],"story":"st_gbl2kwvd2n57nq37uaua","category":"environment","category_p":0.29,"sentiment":"negative","tone":-0.74,"political":0.45},{"id":"n_ccd3td3vj2jspe7z7dgq","seq":793431,"kind":"article","title":"'타그리소' 약효 떨어진 폐암에…AZ·허치메드, 병용치료 美 허가신청","title_en":"'Tagrisso' effectiveness declines in lung cancer... AZ and Hutchmed apply for combination therapy approval in the US","url":"https://www.medipana.com/news/articleView.html?idxno=418445","summary":"아스트라제네카와 허치메드가 \\'타그리소\\' 치료 후 진행한 폐암에 두 경구 표적치료제를 병용하는 전략으로 미국 허가에 도전한다. 기존 EGFR 표적치료에 내성이 생긴 환자 가운데 MET 이상이 확인된 환자를 겨냥한 치료법이다. 허치메드는 29일 아스트라제네카(AstraZeneca, AZ)가 \\'오파티스\\'(ORPATHYS·성분명 사볼리티닙)와 \\'타그리소\\'(오시머티닙) 병용요법의 신약허가신청서(NDA)를 미국 식품의약국(FDA)에 제출했다고 밝혔다. 신청 대상은 EGFR 티로신키나아제 억제제(TKI) 치료 중 또는 치료 후 질병이 진행하고,","published":"2026-09-29T22:40:46Z","seen":"2026-09-30T00:15:49Z","lang":"ko","source":{"id":"kite-cdn-medipana-com-912f9c","name":"cdn.medipana.com","domain":"cdn.medipana.com"},"via":"kite-cdn-medipana-com-912f9c","topics":["medicine","파마시안"],"authors":["최봉선 기자"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q113510355","name":"Hutchison MediPharma Limited","type":"org"},{"id":"Q29006526","name":"Tagrisso","type":"other"}],"story":"st_ccd3td3vj2jspe7z7dgq","category":"health","category_p":0.69,"sentiment":"negative","tone":-0.27,"political":0.15},{"id":"n_owrsz3wykhfpyl6ox7fa","seq":771907,"kind":"article","title":"AstraZeneca takes a £1.5bn stake in US cancer drug developer as it steps up investment in America","url":"https://www.dailymail.com/money/markets/article-16170501/AstraZeneca-takes-1-5bn-stake-US-cancer-drug-developer-steps-investment-America.html","published":"2026-09-29T21:01:00Z","seen":"2026-09-29T21:46:34Z","lang":"en","source":{"id":"dailymail.com","name":"dailymail.com","domain":"dailymail.com"},"via":"gdelt-gkg-english","topics":["economy","science","health","business"],"authors":["Hugo Duncan","HUGO DUNCAN","BUSINESS EDITOR"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"}],"story":"st_owrsz3wykhfpyl6ox7fa","category":"economy-business","category_p":0.83,"sentiment":"positive","tone":0.35,"political":0.17},{"id":"n_vfnobhgx4roseg4onjiq","seq":723241,"kind":"article","title":"AstraZeneca invests $2B in Summit, gaining 'seat at the table' for PD-1/VEGF drug push","url":"https://www.biopharmadive.com/news/summit-astrazeneca-ivonescimab-deal-pd1-vegf/752865","published":"2026-09-29T16:52:22Z","seen":"2026-09-29T16:52:22Z","lang":"en","source":{"id":"biopharmadive.com","name":"biopharmadive.com","domain":"biopharmadive.com"},"via":"gdelt-gkg-english","topics":["economy","health","business"],"authors":["Ben Fidler"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q207326","name":"summit","type":"org"}],"story":"st_deohcpwrj7r4zjgnfhhq","category":"economy-business","category_p":0.68,"sentiment":"positive","tone":0.22,"political":0.24},{"id":"n_lsjmkfo7w3atyjbyfoga","seq":754712,"kind":"article","title":"AstraZeneca pours $2bn into Summit to advance cancer treatment","url":"https://www.bioxconomy.com/partnering/astrazeneca-pours-2bn-into-summit-to-advance-cancer-treatment","published":"2026-09-29T15:04:00Z","seen":"2026-09-29T19:39:25Z","lang":"en","source":{"id":"bioxconomy.com","name":"bioxconomy.com","domain":"bioxconomy.com","outlet":{"wikidata":"Q135641054","name":"BioXconomy","type":"magazine","country":"US","designations":["business","news media","trade magazine"]}},"via":"gdelt-gkg-english","topics":["economy","business","health"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q207326","name":"summit","type":"org"}],"story":"st_nnpgu5v7o6b4smgyr4hq","category":"health","category_p":0.39,"category2":"economy-business","sentiment":"positive","tone":0.5,"political":0.39},{"id":"n_ol3d3xe4i6iqbg64nkna","seq":693440,"kind":"article","title":"AstraZeneca to invest $2bn in Summit for ADC combination therapies","url":"https://www.pharmaceutical-business-review.com/news/astrazeneca-to-invest-2bn-summit-adc-therapies","published":"2026-09-29T14:23:21Z","seen":"2026-09-29T14:23:21Z","lang":"en","source":{"id":"pharmaceutical-business-review.com","name":"pharmaceutical-business-review.com","domain":"pharmaceutical-business-review.com"},"via":"gdelt-gkg-english","topics":["economy","business"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q207326","name":"summit","type":"org"}],"story":"st_nnpgu5v7o6b4smgyr4hq","category":"economy-business","category_p":0.65,"sentiment":"positive","tone":0.09,"political":0.23},{"id":"n_rxzogqfvxwr2tkz2lsgq","seq":690952,"kind":"article","title":"STAT+: AstraZeneca invests $2 billion in Summit Therapeutics","url":"https://www.statnews.com/2026/09/29/biotech-news-astrazeneca-invests-2-billion-in-summit-therapeautics","summary":"AstraZeneca is teaming up with Summit Therapeutics to test its PD-1/VEGF bispecific ivonescimab alongside AstraZeneca’s antibody-drug conjugates.","published":"2026-09-29T13:52:51Z","seen":"2026-09-29T14:18:39Z","lang":"en","country":"US","source":{"id":"kite-statnews-com-165bdc","name":"statnews.com","domain":"statnews.com","outlet":{"wikidata":"Q28452506","name":"Stat","type":"website","designations":["business","news website","website"]}},"via":"kite-statnews-com-165bdc","topics":["healthcare","usa","biotech","business","pharma","the readout","biotechnology","drug development"],"authors":["Meghana Keshavan"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q113503453","name":"Summit Therapeutics","type":"org"}],"image":"https://www.statnews.com/wp-content/uploads/2026/06/GettyImages-2237096018-645x645.jpg","mentions":3,"story":"st_nnpgu5v7o6b4smgyr4hq","category":"economy-business","category_p":0.78,"sentiment":"positive","tone":0.49,"political":0.11},{"id":"n_6dhuglrndxcq4sck3adq","seq":745832,"kind":"article","title":"AstraZeneca To Inject $2B In US Cancer Biopharma","url":"https://www.law360.com/articles/2531130","published":"2026-09-29T13:42:00Z","seen":"2026-09-29T18:40:32Z","lang":"en","source":{"id":"law360.com","name":"law360.com","domain":"law360.com","outlet":{"wikidata":"Q6502903","name":"Law360","type":"news_agency","country":"US","designations":["news agency","website"]}},"via":"gdelt-gkg-english","topics":["economy"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"}],"story":"st_nnpgu5v7o6b4smgyr4hq","category":"economy-business","category_p":0.53,"category2":"health","sentiment":"positive","tone":0.45,"political":0.19},{"id":"n_safpndrukq2ab6m7ziea","seq":686290,"kind":"article","title":"Summit Therapeutics Stock Rockets After AstraZeneca Invests $2 Billion","url":"https://www.investors.com/news/technology/summit-therapeutics-stock-astrazeneca-investment","published":"2026-09-29T13:40:00Z","seen":"2026-09-29T13:52:28Z","lang":"en","source":{"id":"investors.com","name":"investors.com","domain":"investors.com","outlet":{"wikidata":"Q6060911","name":"Investor's Business Daily","type":"newspaper","country":"US","designations":["news website","newspaper","website"]}},"via":"gdelt-gkg-english","topics":["business","economy"],"authors":["Investor's Business Daily","ALLISON GATLIN"],"entities":[{"id":"Q113503453","name":"Summit Therapeutics","type":"org"},{"id":"Q731938","name":"AstraZeneca","type":"org"}],"story":"st_nnpgu5v7o6b4smgyr4hq","category":"economy-business","category_p":0.83,"sentiment":"positive","tone":-0.22,"political":0.05},{"id":"n_kg5khkva5iyc7b35h7za","seq":674254,"kind":"article","title":"AstraZeneca invests $2bn in Summit Therapeutics for cancer drug deal","url":"https://www.financial-news.co.uk/astrazeneca-invests-2bn-in-summit-therapeutics-for-cancer-drug-deal","published":"2026-09-29T11:00:00Z","seen":"2026-09-29T12:57:19Z","lang":"en","country":"GB","source":{"id":"financial-news.co.uk","name":"financial-news.co.uk","domain":"financial-news.co.uk"},"via":"gdelt-gkg-english","topics":["economy","business"],"authors":["Martin Holloway"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q113503453","name":"Summit Therapeutics","type":"org"}],"story":"st_nnpgu5v7o6b4smgyr4hq","category":"economy-business","category_p":0.67,"sentiment":"positive","tone":0.15,"political":0.24},{"id":"n_srv5hr2tlpzajp65tx4a","seq":646529,"kind":"article","title":"FTSE 100 Shares - FTSE 100 rises as AstraZeneca lifts healthcare sector","url":"https://www.livecharts.co.uk/share_prices/FTSE-100-Shares---FTSE-100-rises-as-AstraZene-news1790677083.html","published":"2026-09-29T10:55:17Z","seen":"2026-09-29T10:55:17Z","lang":"en","country":"GB","source":{"id":"livecharts.co.uk","name":"livecharts.co.uk","domain":"livecharts.co.uk"},"via":"gdelt-gkg-english","topics":["business","environment","economy"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"}],"story":"st_srv5hr2tlpzajp65tx4a","category":"economy-business","category_p":0.65,"category2":"health","sentiment":"positive","tone":0.76,"political":0.05},{"id":"n_hsit5ewshbslh7h2q42q","seq":646132,"kind":"article","title":"FTSE Stocks Today - FTSE 100 rises as AstraZeneca lifts healthcare sector","url":"https://www.livecharts.co.uk/share_prices/FTSE-Stocks-Today---FTSE-100-rises-as-AstraZe-news1790677100.html","published":"2026-09-29T10:55:17Z","seen":"2026-09-29T10:55:17Z","lang":"en","country":"GB","source":{"id":"livecharts.co.uk","name":"livecharts.co.uk","domain":"livecharts.co.uk"},"via":"gdelt-gkg-english","topics":["economy","business","environment"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"}],"story":"st_srv5hr2tlpzajp65tx4a","category":"economy-business","category_p":0.64,"category2":"health","sentiment":"positive","tone":0.75,"political":0.03},{"id":"n_fiaalurwbt2kcx7rn7ra","seq":659238,"kind":"article","title":"Summit soars after $2bn investment from AstraZeneca for cancer therapies","url":"https://www.sowetan.co.za/news/world/2026-09-29-summit-soars-after-2bn-investment-from-astrazeneca-for-cancer-therapies","summary":"Summit to test dual cancer therapies in major pharma alliance","published":"2026-09-29T10:46:13Z","seen":"2026-09-29T11:44:28Z","lang":"en","country":"ZA","source":{"id":"kite-sowetan-co-za-f35324","name":"sowetan.co.za","domain":"sowetan.co.za"},"via":"kite-sowetan-co-za-f35324","topics":["sci-tech"],"authors":["Reuters Agency"],"entities":[{"id":"Q207326","name":"summit","type":"org"},{"id":"Q731938","name":"AstraZeneca","type":"org"}],"image":"https://www.sowetan.co.za/resizer/v2/2I32RZNLKBE5RF6ZHGVZUDA64Q.JPG?auth=7ccd3aedbe205e6d213ada462f824903f8f4d4e7d8fa06f9ef81ae92bc103749&height=3544&smart=true&width=5081","story":"st_nnpgu5v7o6b4smgyr4hq","category":"economy-business","category_p":0.85,"sentiment":"positive","tone":0.69,"political":0.11},{"id":"n_re7kgerx7bdqdmij2hha","seq":646646,"kind":"article","title":"AstraZeneca invests $2b in Summit Therapeutics to accelerate cancer drug development - London Business News","url":"https://londonlovesbusiness.com/astrazeneca-invests-2b-in-summit-therapeutics-to-accelerate-cancer-drug-development","published":"2026-09-29T10:06:00Z","seen":"2026-09-29T10:55:17Z","lang":"en","source":{"id":"londonlovesbusiness.com","name":"londonlovesbusiness.com","domain":"londonlovesbusiness.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Amy Johnson LLB Finance Reporter"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q113503453","name":"Summit Therapeutics","type":"org"}],"story":"st_nnpgu5v7o6b4smgyr4hq","category":"economy-business","category_p":0.77,"sentiment":"positive","tone":0.57,"political":0.12},{"id":"n_deohcpwrj7r4zjgnfhhq","seq":633852,"kind":"article","title":"AstraZeneca scales Summit's PD-1xVEGF strategy with $2B investment to fuel ADC combos","url":"https://www.fiercebiotech.com/biotech/astrazeneca-scales-summits-pd-1xvegf-strategy-2b-investment-fuel-adc-combinations","published":"2026-09-29T09:54:17Z","seen":"2026-09-29T09:54:17Z","lang":"en","source":{"id":"fiercebiotech.com","name":"fiercebiotech.com","domain":"fiercebiotech.com"},"via":"gdelt-gkg-english","topics":["health","economy"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q207326","name":"summit","type":"org"}],"story":"st_deohcpwrj7r4zjgnfhhq","category":"economy-business","category_p":0.79,"sentiment":"positive","tone":0.27,"political":0.21},{"id":"n_fnv3vfqfycl2ifk5rela","seq":633624,"kind":"article","title":"AstraZeneca invests £1.5bn into US firm Summit for cancer drug tie-up","url":"https://www.stratford-herald.com/national/astrazeneca-invests-1-5bn-into-us-firm-summit-for-cancer-drug-tie-up-172288","published":"2026-09-29T09:54:17Z","seen":"2026-09-29T09:54:17Z","lang":"en","source":{"id":"stratford-herald.com","name":"stratford-herald.com","domain":"stratford-herald.com","outlet":{"wikidata":"Q128846953","name":"Stratford-upon-Avon Herald","type":"newspaper","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","business","science","health"],"entities":[{"id":"Q731938","name":"AstraZeneca","type":"org"},{"id":"Q207326","name":"summit","type":"org"},{"id":"Q141503649","name":"Cancer Drug","type":"other"}],"story":"st_nnpgu5v7o6b4smgyr4hq","category":"economy-business","category_p":0.77,"sentiment":"positive","tone":0.32,"political":0.27}]}